Here is What Hedge Funds Think About Tandem Diabetes Care Inc (TNDM)

Page 2 of 2

As industrywide interest jumped, some big names were breaking ground themselves. Broadfin Capital, led by Kevin Kotler, created the largest position in Tandem Diabetes Care Inc (NASDAQ:TNDM). Broadfin Capital had $2.6 million invested in the company at the end of the quarter. Ken Griffin’s Citadel Investment Group also made a $0.1 million investment in the stock during the quarter.

Let’s also examine hedge fund activity in other stocks similar to Tandem Diabetes Care Inc (NASDAQ:TNDM). We will take a look at Enzo Biochem, Inc. (NYSE:ENZ), vTv Therapeutics Inc (NASDAQ:VTVT), ImmunoGen, Inc. (NASDAQ:IMGN), and TerraVia Holdings, Inc. (NASDAQ:TVIA). This group of stocks’ market caps are closest to TNDM’s market cap.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
ENZ 12 17117 0
VTVT 3 2485 0
IMGN 13 38247 -3
TVIA 3 7093 -2

As you can see these stocks had an average of 8 hedge funds with bullish positions and the average amount invested in these stocks was $16 million. That figure was $34 million in TNDM’s case. ImmunoGen, Inc. (NASDAQ:IMGN) is the most popular stock in this table. On the other hand vTv Therapeutics Inc (NASDAQ:VTVT) is the least popular one with only 3 bullish hedge fund positions. Tandem Diabetes Care Inc (NASDAQ:TNDM) is not the most popular stock in this group but hedge fund interest is still above average. This is a slightly positive signal but we’d rather spend our time researching stocks that hedge funds are piling on. In this regard IMGN might be a better candidate to consider taking a long position in.

Page 2 of 2